Effects of intraperitoneally injected silver nanoparticles on histological structures and blood parameters in the albino rat

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1505-1517

  Sarhan, Osama Mohamed M ^a,b   Hussein, Rehab M ^c  

^a FAYOUM UNIVERSITY   (Egypt)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Blood; Kidney; Liver; Rat; Silver nanoparticles; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GLYCOGEN; HEMOGLOBIN; SILVER NANOPARTICLE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBINO RAT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BOWMAN SPACE OBLITERATION; CELL SWELLING; CELL VACUOLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOPLASM; CYTOTOXICITY; ELECTRON MICROSCOPY; ENDOSOME; GLOMERULOPATHY; GLYCOGEN LIVER LEVEL; GRANULOCYTE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY STRUCTURE; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE BASEMENT MEMBRANE THICKENING; KIDNEY TUBULE DISORDER; KIDNEY TUBULE EPITHELIUM; KIDNEY TUBULE EPITHELIUM SWELLING; KUPFFER CELL; LEUKOCYTE COUNT; LIPID STORAGE; LIVER CELL DAMAGE; LIVER DISEASE; LIVER LYSOSOME; LIVER SINUSOID; LIVER SINUSOID NARROWING; LIVER STRUCTURE; LYMPHOCYTE COUNT; MALE; MITOCHONDRIAL CRISTAE; MITOCHONDRION; NONHUMAN; PODOCYTE; PODOCYTE ELONGATION; PODOCYTE SWELLING; RAT; RAT STRAIN; TOXICITY TESTING; UREA BLOOD LEVEL;

BLOOD; KIDNEY; LIVER; RAT; SILVER NANOPARTICLES; TOXICITY;

ANIMALS; BLOOD CELLS; INJECTIONS, INTRAPERITONEAL; KIDNEY; LIVER; MALE; MATERIALS TESTING; METAL NANOPARTICLES; RATS; SILVER;

EID: 84897093824     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S56729     Document Type: Article

References (61)

1. Barnes C, Elsaesser A, Arkusz J, et al. Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett. 2008;8:3069-3074.
2. Thomas K, Sayre P. Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials. Toxicol Sci. 2005;87:316-321.
3. Drakel PL, Hazelwood KJ. Exposure-related health effects of silver and silver compounds: a review. Ann Occup Hyg. 2005;49:575-585.
4. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176:1-12.
5. Reddy TK, Reddy SJ, Prasad, et al. Effect of silver nanoparticles on energy metabolism in selected tissues of Aeromonas hydrophila infected Indian major Carp, Catlacatla. IOSR J Pharmacy. 2013;3:49-55.
6. Tavares P, Balbinot F, de Olivera HM, et al. Evaluation of genotoxic effect of silver nanoparticles (AgNPs) in vitro and in vivo. J Nanopart Res. 2012;14:791.
7. Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong K. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci. 2011;73:1417-1423.
8. Khodadadi S, Naghsh N, Mashayekh A. Effect of silver nanoparticle on phosphocreatine kinase and histological changes of skeletal muscle tissue in male Wistar rat. Available from: http://congress.mazums.ac.ir/jmums/files/site1/user_files_0d0bf0/t_mousavi-A-10-1466-21-e3892c2.pdf. Accessed February 5, 2014.
9. Tiwari DK, Jin T, Behari J. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods. 2011;21: 13-24.
10. Atiyeh BS, Costagliola M, Hayek SN, Dipo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns. 2007;33:139-148.
11. Sardari RR, Zarchi SR, Talebi A, et al. Toxicological effects of silver nanoparticles in rats. Afr J Microbiol Res. 2012;6:5587-5593.
12. Park E, Bae E. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharm. 2010;30:162-168.
13. Kim JS, Song KS, Sung TH, et al. Genotoxicity, acute oral and dermal eye and dermal irritation and corrosion and skin sensitization evaluation of silver nanoparticles. Nantoxicology. 2013;7:953-960.
14. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005;88:412-419.
15. Tang J. Status of biological evaluation on silver nanoparticles. J Biomed Eng. 2008;25:958-961.
16. Kim YS, Song MY, Park JD, et al. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol. 2010;10:20.
17. Reitman S, Frankel S. A colourimetric method of serum glutamic oxalo acetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1975;28: 56-63.
18. Henry RJ. Clinical Chemistry. Principles and Techniques. 2nd ed. Hagerstown, MD, USA: Harper and Row; 1974.
19. Bozzola JJ, Russell LD. Specimen staining and contrast methods for transmission electron microscopy. In: Bozzola JJ, Russell LD, editors. Electron Microscopy. Principles and Techniques for Biologists. Boston, MA, USA: Jones and Bartlett Publishers, Boston; 1992;5.
20. Choi O, Deng KK, Kim NJ, Ross L Jr, Surampalli RY, Hu Z. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 2008;42:3066-3074.
21. Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008;4:707-716.
22. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53: 283-318.
23. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55: 329-347.
24. Alt V, Bechert T, Steinrücke P, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials. 2004;25:4383-4391.
25. Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol. 2009;43:6046-6051.
26. Kim S, Choi JE, Choi J, et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol in Vitro. 2009;23: 1076-1084.
27. Huo Y, Li G, Duan RF, et al. PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts. Free Radic Biol Med. 2008;44:1578-1591.
28. Costa CS, Ronconi JVV, Daufenbach JE, et al. In vitro effects of silver nanoparticles on the mitochondrial respiratory chain. Mol Cell Biochem. 2010;342:51-56.
29. Kim S, Kim S, Lee S, et al. Characterization of the effects of silver nanoparticles on liver cells using HR-MAS NMR spectroscopy. Bull Korean Chem Soc. 2011;32:2021-2026.
30. Abdelhalim MA. Gold nanoparticles administration induces disarray of heart muscle; hemorrhagic, chronic inflammatory cells infiltrated by small lymphocytes, cytoplasmic vacuolization and congested blood vessels. Lipids Health Dis. 2011;10:233-241.
31. Yasin S, Liu L, Yao J. Biosynthesis of silver nanoparticles by bamboo leaves extract and their antimicrobial activity. Journal of Fiber Bioengineering and Informatics. 2013;6(1):77-84.
32. Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3:145-150.
33. Wei L, QunFang Z, JiYan L, et al. Environmental and biological influences on the stability of silver nanoparticles. Chinese Science Bulletin. 2011;56:2009-2015.
34. Gilbert B, Ono RK, Ching KA, et al. The effects of nanoparticle aggregation processes on aggregate structure and metal uptake. J Colloid InterfSci. 2009;339:285-295.
35. Wick P, Manser P, Limbach LK, et al. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. ToxicolLett. 2007;168: 121-131.
36. Umbreit TH, Franke-Carroll S, Weaver JL, et al. Tissue distribution and histopathological effects of titanium dioxide nanoparticles after intravenous or subcutaneous injection in mice. J Appl Toxicol. 2012;32: 350-357.
37. Austin CA, Umbreit TH, Brown KM, et al. Distribution of silver nanoparticles in pregnant mice and developing embryos. Nanotoxicology. 2012;6:912-922.
38. Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci. 2001;90:1927-1936.
39. Oh E, Delehanty JB, Sapsford KE, et al. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. ACS Nano. 2011;5:6434-6448.
40. Pan Y, Leifert A, Ruau D, et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small. 2009;5:2067-2076.
41. Zhang Q, Hitchins VM, Scharand AM, Hussain SM, Goering PL. Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators. Nanotoxicology. 2011;5:284-295.
42. Moffat DB, Creasey M. The distribution of ingested silver in the kidney of the rat and of the rabbit. Acta Anat. 1972;83:346-355.
43. Loeschner K, Hadrup N, Qvortrup K, et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol. 2011;8:18.
44. Yousef J, Hendi H, Hakami SF, et al. Toxicity of silver nanoparticles after Injected intraperitoneally in rats. J Am Sci. 2012;8:589-593.
45. Day WA, Hunt JS, McGiven AP. Silver deposition in mouse glomeruli. Pathology. 1976;8:201-204.
46. Terentyuk GN, Maslyakova GN, Suleymanova LV, et al. Morphological and biochemical changes after intravenous injection of gold nanoparticles. SPIE Proceedings of 7th international Conference on Photonics and Imaging in Biology and Medicine. 2009;7280:155-163.
47. Derfus AM, Chan WCW, Bhatia SN. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv Mater. 2004;16: 961-966.
48. Kogan MJ, Bastus NG, Amigo R, et al. Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett. 2006;6: 110-115.
49. Noginov MA, Zhu G, Bahoura M, et al. The effect of gain and absorption on surface plasmos in metal nanoparticles. Appl Phys B. 2007;86: 455-460.
50. Asharani PV, Mun GLK, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3:279-290.
51. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40:328-346.
52. Danscher G. Light and electron microscopic localization of silver in biological tissue. Histochemistry. 1981;71:171-186.
53. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005;19:975-983.
54. Asharani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 2009;10:65.
55. Ahamed M, Alsalhi MS, Siddiqui MK. Silver nanoparticle applications and human health. Clin Chim Acta. 2010;411:1841-1848.
56. Paula MM, da Costa CS, Baldin NC, et al. In vitro effect of silver nanoparticles on creatine kinase activity. J Braz Chem Soc. 2009;20: 1556-1560.
57. Duffin R, Tran L, Brown D, Stone V, Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol. 2007;19:849-856.
58. Shin SH, Ye MK, Kim HS, Kang HS. The effects of nanosilver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol. 2007;7:1813-1818.
59. Gopinath P, Gogoi SK, Sanpui P et al. Signaling gene cascade in silver nanoparticle induced apoptosis. Colloid Surf B Biointerfaces. 2010;77: 240-245.
60. Kim YS, Kim JS, Cho HS, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol. 2008;20:575-583.
61. Loeb WF, Quimby FW, editors. The Clinical Chemistry of Laboratory Animals. 2nd ed. Philadelphia, PA, USA: Taylor & Francis; 1999.